Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva Pharmaceutical Industries Ltd. – Artonpapers
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Shares Plunge as CEO Steps Down From Israeli Pharmaceutical Giant – The Forward
Teva Stock Price Rises - Wise Money Israel
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Teva Pharmaceuticals Stock Jumps After Reporting Earnings. What You Need to Know. | Barron's
Israel Not Aiming to Punish Teva on Job Cuts, Official Says - Bloomberg
In Israel's largest acquisition, Teva buys Allergan Generics for $40.5b - The Jerusalem Post
Teva Falls Hard, Loses Title as Israel's Biggest Firm - TheStreet
Israel's TEVA, PERI Tank on Q4 Earnings; IZRL in Focus - TipRanks.com
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Opioid lawsuit concerns hit Teva - Globes
Ex-pharmaceutical company boss faces insider trading charges over Teva deal | The Times of Israel
Teva stock gains on new growth strategy; Evercore upgrades | Seeking Alpha
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
Why Warren Buffett's Berkshire loves loathed Israeli drug stock Teva
Teva shares plummet amid CEO departure and bribery reports
Teva stock downgraded to neutral by UBS on heels of $85 million opioid settlement - MarketWatch
Teva Stock: What We Know, And Don't, About The Adderall Shortage | Investor's Business Daily
Teva's shares surge as first quarter results beat expectations | The Times of Israel
